Clinical Trials in New York

Showing 8621-8640 of 22,668 trials

The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia

NCT05172687

This study aims to analyze how warning letters sent to physicians prescribing high levels of the antipsychotic quetiapine affected the health and quality of life of their patients with dementia. Using a randomized controlled trial conducted by the Centers for Medicare and Medicaid Services (CMS) in 2015, this secondary study looks at the effects of potential de-prescribing of antipsychotics by study physicians induced by the letters. The central question is whether the intervention led to better health and quality of life outcomes by encouraging more guideline-concordant care and whether changes in physicians' prescription behavior caused unintended harms.

Alzheimer DiseaseDementiaPrescribing, Off-Label

Columbia University336,460 participantsStarted Apr 2015

Boston, Massachusetts, United States • Cambridge, Massachusetts, United States • New York, New York, United States

TERMINATEDPhase 2< 1 mile

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

NCT04461600

The current study is designed to evaluate the efficacy and safety of AL101 monotherapy in subjects with Notch-activated recurrent or metastatic TNBC; Notch activation will be determined by a Next Generation Sequencing (NGS) test.

Triple Negative Breast Cancer

Ayala Pharmaceuticals, Inc,18 participantsStarted Aug 2020

Gilbert, Arizona, United States • Phoenix, Arizona, United States • San Francisco, California, United States +26 more locations

The Effect of De-Prescribing Antipsychotics on Health and Quality of Life for People With Dementia

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

Find Trials by Condition in New York

A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Registry of CytoSorb Therapy in COVID-19 ICU Patients

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

Aromatherapy With Lavender as Anxiolysis Prior to Cataracts Surgery

Adjunctive Vortioxetine in Schizophrenia

Belimumab in Idiopathic Inflammatory Myositis

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

Practice of Acceptance, Awareness, and Compassion in Caregiving (PAACC)

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Lung EpiCheck Biomarkers Development Study

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis